A community-based assessment of correlates of facility delivery among HIV-infected women in western Kenya

listen audio

Study Justification:
This study aimed to assess the factors influencing facility delivery among HIV-infected women in western Kenya. The justification for this study is that facility delivery is crucial for reducing maternal morbidity and mortality, improving fetal outcomes, and preventing mother-to-child transmission of HIV. Despite high access to antenatal care in Kenya, less than half of births occur at health facilities. Understanding the barriers to facility delivery among HIV-infected women can help inform interventions to increase utilization of these services.
Study Highlights:
– The study found that overall, 46.8% of HIV-infected women and 39.9% of HIV-uninfected women delivered at health facilities.
– Primary disincentives for facility delivery among HIV-infected women included cost, distance, fear of harsh treatment, and fear of HIV testing.
– HIV-infected women who delivered at facilities had higher education and socioeconomic status, initiated antenatal care earlier, were more likely to know their partner’s HIV status, reported satisfaction with delivery care, and used antiretrovirals compared to those with non-facility delivery.
– Similar factors influencing facility delivery were noted among HIV-uninfected women.
Recommendations for Lay Reader and Policy Maker:
1. Addressing Barriers: The study highlights the need to address barriers such as cost, distance, and fear of harsh treatment that discourage facility delivery among HIV-infected women. Interventions should focus on reducing financial burdens, improving access to health facilities, and ensuring respectful and supportive care for pregnant women.
2. Targeting Vulnerable Groups: HIV-infected women with lower socioeconomic status and those who present late to antenatal care should be prioritized for interventions to increase facility delivery. These women may require additional support and resources to overcome barriers and access appropriate care.
3. Partner Involvement: Partner involvement in maternity services can be a key factor in increasing facility delivery. Couples counseling and education programs should be promoted to encourage joint decision-making and support for facility delivery.
Key Role Players:
1. Ministry of Health: The Ministry of Health should play a leading role in implementing interventions to increase facility delivery among HIV-infected women. They can provide policy guidance, allocate resources, and coordinate efforts with other stakeholders.
2. Healthcare Providers: Healthcare providers, including doctors, nurses, and midwives, play a crucial role in delivering quality care and addressing the specific needs of HIV-infected women. They should receive training on HIV-related issues, stigma reduction, and respectful maternity care.
3. Community Health Workers: Community health workers can play a vital role in raising awareness, providing education, and facilitating access to health services. They can help identify and support HIV-infected women who may face barriers to facility delivery.
4. Non-Governmental Organizations (NGOs): NGOs working in the field of maternal and child health, HIV/AIDS, and women’s rights can contribute by implementing programs and interventions to increase facility delivery. They can provide support, advocacy, and resources to address the identified barriers.
Cost Items for Planning Recommendations:
1. Training and Capacity Building: Budget should be allocated for training healthcare providers on HIV-related issues, stigma reduction, and respectful maternity care. This includes workshops, materials, and ongoing support.
2. Infrastructure and Equipment: Investment in health facility infrastructure and equipment is necessary to ensure safe and quality delivery services. This may include renovations, equipment procurement, and maintenance.
3. Outreach and Awareness Campaigns: Resources should be allocated for community outreach and awareness campaigns to educate women and their partners about the benefits of facility delivery and address misconceptions or fears.
4. Support Services: Additional resources may be needed to provide support services such as transportation assistance, counseling, and psychosocial support for HIV-infected women accessing facility delivery.
5. Monitoring and Evaluation: Budget should be allocated for monitoring and evaluation activities to assess the impact of interventions and ensure accountability. This includes data collection, analysis, and reporting.
Please note that the cost items provided are general categories and not actual cost estimates. The specific budget requirements will depend on the context, scale, and duration of the interventions.

The strength of evidence for this abstract is 8 out of 10.
The evidence in the abstract is strong because it presents findings from a community-based survey and utilizes multivariate logistic regression to assess correlates of facility delivery among HIV-infected women in western Kenya. The study also compares these correlates to HIV-uninfected women from the same region. The sample size is adequate, and statistical tests are used to analyze the data. The abstract provides specific percentages and p-values to support the findings. However, to improve the evidence, the abstract could include more information about the sampling methodology, such as the randomization process and any potential biases. Additionally, it would be helpful to include information about the generalizability of the findings and any limitations of the study.

Background: Childbirth at health facilities is an important strategy to reduce maternal morbidity and mortality, improve fetal outcomes, and reduce mother-to-child transmission of HIV. Although access to antenatal care in Kenya is high (>90%), less than half of births occur at health facilities. This analysis aims to assess correlates of facility delivery among recently pregnant HIV-infected women participating in a community-based survey, and to determine whether these correlates were unique when compared to HIV-uninfected women from the same region. Methods: Women residing in the Kenya Medical Research Institute/Centers for Disease Control and Prevention Health and Demographic Surveillance System, and who had delivered an infant in the previous year were visited at home in 2011. Consenting mothers answered a questionnaire assessing demographics, place of delivery, utilization of prevention of mother-to-child HIV transmission (PMTCT) services, and stigma indicators. Known HIV-positive women were purposively oversampled. Chi-square tests of proportions and multivariate logistic regression, stratified by HIV status, were performed to assess correlates of facility delivery. Results: Overall, 101 (46.8%) HIV-infected and 127 (39.9%) HIV-uninfected women delivered at health facilities. Among HIV-infected women, cost (42.8%), distance (18.8%) and fear of harsh treatment (15.2%) were primary disincentives for facility delivery; 2.9% noted fear of HIV testing was a disincentive. HIV-infected women who delivered at facilities had higher education (p = 0.04) and socioeconomic status (p < 0.005), initiated antenatal care (ANC) earlier (4.9 vs. 5.4 months, p = 0.016), were more likely to know partner's HIV status (p = 0.016), report satisfaction with delivery care (p = 0.001) and use antiretrovirals (87.1% vs. 77.4%, p = 0.063) compared to those with non-facility delivery. Stigma indicators were not associated with delivery location. Similar cofactors of facility delivery were noted among uninfected women. Conclusions: Utilization of facility delivery remains low in Kenya and poses a challenge to elimination of infant HIV and reduction of peripartum mortality. Cost, distance, and harsh treatment were cited as barriers and these need to be addressed programmatically. HIV-infected women with lower socioeconomic status and those who present late to ANC should be prioritized for interventions to increase facility delivery. Partner involvement may increase use of maternity services and could be enhanced by couples counseling.

This analysis utilized data obtained from a cross-sectional study of women residing in the Kenya Medical Research Institute/Centers for Disease Control and Prevention (KEMRI/CDC) Health and Demographic Surveillance System (HDSS) area who delivered an infant within a year prior to the survey. The KEMRI/CDC HDSS area is located northeast of Lake Victoria in the Nyanza Province of western Kenya [19]. The HDSS covers 385 villages with a population of approximately 220,000. The HDSS had implemented a program for home-based counseling and testing (HBCT) for HIV with high uptake of testing and linkage of HIV test result to HDSS dataset for all consenting participants. HIV-infected women were purposively oversampled to increase power of the study to detect associations related to uptake of PMTCT interventions. The methodology of the parent study has previously been described [20]. A list of women in the KEMRI-CDC HDSS area who had delivered in 2010 was generated. The sampling framework was designed to efficiently assess two populations relevant to PMTCT service delivery: a random sample of women in the general community to assess uptake of interventions targeting all pregnant women (ANC, HIV-testing), and a sample of known HIV positive women to assess uptake of interventions (antiretrovirals) targeting HIV-infected pregnant women. This included a comprehensive list of 275 women who had received their HIV status for at least 3 months before delivery and a second list of 523 randomly selected women from the areas where HBCT had not been conducted. Data generated from the HDSS included name, Global Positioning System location, and a randomly assigned identification code. Despite lead investigator knowledge of HIV status from the HDSS in HBCT areas for sampling purposes, field workers were blinded to HIV status and thus self-report of HIV status was used at interview. Outcomes of interest included self-report of place of delivery. Cofactors assessed for place of delivery included age, education level, marital status, utilization of antenatal care (ANC), use of maternal and infant ARVs, satisfaction with care provided during delivery and knowledge of partner HIV status. Socioeconomic status was assessed by using indicators such ownership of mobile phones, radio, bicycle, cattle and monthly family income. Standardized questions were used to quantitatively measure HIV-related stigma and discrimination [21]. We evaluated two domains of HIV stigma, namely: value- and morality-related attitudes of blame, judgment and shame for those living with HIV/AIDS; and enacted stigma or discrimination. To assess perceptions of community behavior, or perhaps reasons that women were unwilling to report themselves about reasons for non-facility delivery, all participants were also asked an open-ended question, “In your opinion, what are some of the reasons women in this area do not deliver their babies in a health facility?”. Analyses were restricted to women self-reporting HIV-positive status or HIV-negative status. Those who reported not knowing their status, and those who reported they were negative but who were known to be HIV-positive through prior HBCT, were excluded. STATA version 10 (STATA Corp, College Station, Texas, USA) was used to analyze data on rates and correlates of facility delivery and association of facility delivery with use of maternal and infant antiretrovirals. We used Pearson’s Chi square or Fisher’s exact tests to compare categorical variables, and t-tests were used for continuous variables. Multivariate logistic regression was conducted using covariates statistically associated (p < 0.05) with facility delivery in univariate analysis. Approval for the study was obtained from the Kenya Medical Research Institute (KEMRI) Ethical Review Committee (ERC), and from the Human Subjects Division at the University of Washington. Authorization was also obtained from Provincial Medical Officer, Nyanza and the District Medical Officers of Health. Study participants provided written informed consent to be interviewed and to have their survey data linked to their HDSS record.

Based on the provided information, here are some potential innovations that could improve access to maternal health:

1. Mobile health clinics: Implementing mobile health clinics that can travel to remote areas and provide essential maternal health services, including antenatal care and delivery assistance.

2. Telemedicine: Utilizing telemedicine technology to connect healthcare providers with pregnant women in remote areas, allowing for virtual consultations and monitoring throughout pregnancy and childbirth.

3. Community health workers: Training and deploying community health workers who can provide education, support, and basic healthcare services to pregnant women in their own communities, helping to increase awareness and access to maternal health services.

4. Financial incentives: Introducing financial incentives, such as cash transfers or subsidies, to encourage pregnant women to seek facility-based deliveries and overcome barriers related to cost.

5. Addressing stigma: Implementing interventions to address stigma related to HIV and facility-based deliveries, including community education campaigns and counseling services to reduce fear and discrimination.

6. Improving transportation: Enhancing transportation infrastructure and services in remote areas to ensure that pregnant women have reliable and affordable means of reaching healthcare facilities for delivery.

7. Partner involvement: Promoting partner involvement in maternal health by providing couples counseling and education, encouraging men to support and accompany their partners to healthcare facilities for antenatal care and delivery.

8. Strengthening healthcare facilities: Investing in the improvement and expansion of healthcare facilities in underserved areas, ensuring they have the necessary resources, equipment, and skilled healthcare providers to provide quality maternal health services.

These innovations can help address the barriers identified in the study, such as cost, distance, fear of harsh treatment, and late initiation of antenatal care, and ultimately improve access to maternal health services for HIV-infected and HIV-uninfected women in western Kenya.
AI Innovations Description
Based on the description provided, the recommendation to improve access to maternal health is to address the barriers of cost, distance, and fear of harsh treatment that were identified in the analysis. This can be done through the following strategies:

1. Financial support: Implement programs or initiatives that provide financial assistance to pregnant women, particularly those who are HIV-infected and have lower socioeconomic status. This can help alleviate the cost barrier associated with facility delivery.

2. Transportation services: Improve transportation infrastructure and provide transportation services to ensure that pregnant women have access to health facilities within a reasonable distance. This can help overcome the barrier of distance.

3. Sensitization and training: Conduct sensitization campaigns and provide training to healthcare providers to ensure that they provide respectful and compassionate care to all pregnant women, regardless of their HIV status. This can help address the fear of harsh treatment and stigma associated with facility delivery.

4. Early initiation of antenatal care (ANC): Promote early initiation of ANC among HIV-infected women by raising awareness about the importance of ANC and its benefits. This can help improve the likelihood of facility delivery and increase the utilization of prevention of mother-to-child HIV transmission (PMTCT) services.

5. Partner involvement: Encourage partner involvement in maternity services through couples counseling and education. This can help increase support for facility delivery and improve maternal and infant outcomes.

By implementing these recommendations, it is possible to improve access to maternal health services, increase facility delivery rates, and ultimately reduce maternal morbidity and mortality, improve fetal outcomes, and reduce mother-to-child transmission of HIV.
AI Innovations Methodology
Based on the provided description, here are some potential recommendations for improving access to maternal health:

1. Reduce cost barriers: Develop programs or policies that provide financial assistance or subsidies to pregnant women, particularly HIV-infected women, to cover the costs associated with facility delivery. This could include covering transportation expenses or reducing fees for delivery services.

2. Improve transportation infrastructure: Enhance transportation networks in rural areas to make it easier for pregnant women to access health facilities. This could involve building or improving roads, providing public transportation options, or implementing mobile health clinics.

3. Address fear of harsh treatment: Implement training programs for healthcare providers to ensure respectful and compassionate care for all pregnant women, including those who are HIV-infected. This can help alleviate fears and encourage more women to choose facility delivery.

4. Increase community awareness and education: Conduct community-based education campaigns to raise awareness about the benefits of facility delivery and the available services for maternal health. This can help dispel misconceptions and encourage more women to seek care at health facilities.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could be developed as follows:

1. Define the indicators: Identify specific indicators that can measure the impact of the recommendations on access to maternal health. This could include the percentage of women choosing facility delivery, the average distance traveled to reach a health facility, or the percentage of women reporting satisfaction with delivery care.

2. Collect baseline data: Gather data on the current status of access to maternal health in the target area. This can be done through surveys, interviews, or existing data sources. Collect information on the indicators identified in step 1.

3. Implement interventions: Introduce the recommended interventions in the target area. This could involve implementing financial assistance programs, improving transportation infrastructure, conducting training programs for healthcare providers, and launching community education campaigns.

4. Monitor and evaluate: Continuously monitor the implementation of the interventions and collect data on the indicators identified in step 1. This can be done through surveys, interviews, or data collection systems. Compare the data to the baseline data collected in step 2 to assess the impact of the interventions.

5. Analyze and interpret the data: Analyze the collected data to determine the extent to which the interventions have improved access to maternal health. This can involve statistical analysis, such as comparing percentages or conducting regression analysis. Interpret the findings to understand the effectiveness of each intervention and identify areas for improvement.

6. Adjust and refine interventions: Based on the findings from the data analysis, make adjustments and refinements to the interventions as needed. This could involve scaling up successful interventions, modifying strategies that are not yielding the desired results, or introducing new interventions based on the identified gaps.

7. Repeat the process: Continuously repeat steps 3 to 6 to iteratively improve access to maternal health. Monitor the impact of the interventions over time and make ongoing adjustments to ensure sustained improvements.

By following this methodology, it is possible to simulate the impact of the recommendations on improving access to maternal health and make evidence-based decisions for further interventions.

Yabelana ngalokhu:
Facebook
Twitter
LinkedIn
WhatsApp
Email